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kidney development | metanephric mesenchyme | Mtor | nephron progenitor cells | Tsc1 M ammalian nephrogenesis progresses through a series of developmental stages during mid to late gestation culminating with the metanephros, which persists as the definitive kidney in the adult. The kidneys contain multiple nephrons, consisting of glomerular capillary tufts surrounded by parietal epithelial capsules and a connecting network of tubules that modify glomerular filtrate composition to aid in fluid and salt homeostasis and perform different metabolic functions, including vitamin D metabolism. The associated juxtaglomerular apparatus contributes to hormonal regulation of blood pressure. Nephrogenesis ends by the 36th week of gestation in humans (1, 2) and by the third day of life in mice (2, 3) . The number of nephrons in individual kidneys may vary 10-fold, from ∼200,000 to over 2.5 million. Not all factors contributing to this variation are known, but prematurity, intrauterine growth retardation, and maternal starvation during gestation are strongly associated with low nephron endowment (4) . Low nephron numbers contribute to significantly increased risk of chronic kidney disease (CKD), hypertension, and end-stage renal disease (5) (6) (7) (8) . As the postnatal kidney can repair but not replace nephrons, intervention-free survival depends on the initial nephron number. The burden of renal and cardiovascular disease is immense: More than eight million Americans are affected by CKD, and over 100,000 begin dialysis each year while awaiting renal transplantation, mainly secondary to obesity, diabetes, and hypertension. Thus, a greater understanding of the basic mechanisms regulating nephron endowment and any indication of a path to increasing nephron numbers are of marked scientific and clinical relevance.
Nephron progenitor cells (NPCs) in the metanephric mesenchyme (MM) coalesce into "cups" around ureteric bud (UB) tips. Reciprocal interactions between the UB and NPCs induce differentiation of two nephron primordia, one at each "arm pit" of the new branch (9, 10), via a mesenchymal-epithelial transition in response to UB-derived Wnt9b (11, 12) . The NPCs in turn produce GDNF and other signals that induce and maintain UB branching (13) . Six2, a transcription factor, maintains the NPC population; Six2 deletion in the NPC leads to the loss of nephrons due to premature differentiation (14) (15) (16) . Differentiating NPCs extinguish Six2 and create nephrons through formation of an epithelial renal vesicle, which grows into a comma-shaped and then into an S-shaped body. Using an ex vivo transplantation assay, we have demonstrated that postnatal day 0 (P0) progenitors preferentially exit the stem cell niche and differentiate into nephrons relative to young NPCs. Importantly, P0 NPCs can remain in the niche if surrounded by E12.5 Fgf20 + progenitors (17) or can selfrenew in culture nearly indefinitely (18) (19) (20) , indicating tunable plasticity. NPC populations are heterogeneous, shifting with embryonic age toward a signature rich with ribosomal components, PolyA-binding proteins, and other transcripts suggestive of an increase in Mtor (mammalian target of rapamycin) activity (17) . Mtor, a serine/threonine kinase, serves as a central regulator of cell metabolism, growth, proliferation, autophagy, and survival when in complex with Raptor (forming Mtor complex 1, Mtorc1) or Rictor (forming Mtorc2). Hamartin (coded by the Tuberous sclerosis 1 gene, Tsc1), a protein widely expressed in normal tissues, complexes with tuberin (Tsc2) (21, 22) and inhibits MtorC1.
Significance
Mammals form the final numbers of nephrons, the functional units of their kidneys, before or within a few days after birth. This initial endowment declines throughout life without the ability to replace nephrons lost to injury. Therefore, humans with low nephron numbers (such as premature infants) have higher rates of kidney disease in adulthood. Here we report that partial reduction in hamartin activity within mouse renal progenitors can lead to a significant increase in nephron numbers in newborns. Nephrogenesis was prolonged by at least a day and correlated with higher engraftment rates in the developing niche in a stem cell engraftment assay. We provide evidence that this phenotype is independent of the inhibitory effect of hamartin on the Mtor complex.
These findings motivated us to investigate the role of Mtor and Tsc1 in tuning NPC plasticity.
Herein we report that conditional deletion of Mtor in NPC profoundly disrupted nephrogenesis, and hemizygous deletion led to a significant reduction in nephron endowment. By contrast, conditional deletion of Tsc1 led to a lethal proximal tubular lesion. Surprisingly, hemizygous deletion of Tsc1 was associated with significantly (25%) increased nephron numbers due to the delayed cessation of nephrogenesis. Accordingly, NPCs hemizygous for Tsc1 displayed increased stem cell niche engraftment relative to age-matched wild-type cells, which could reflect a slower rate of aging. Finally, epistasis experiments demonstrated that the effects of Tsc1 deletion were not dependent on its interaction with the Mtor pathway. This suggests that a hamartin target is one variable affecting nephron endowment, representing a potential therapeutic approach to augment nephrogenesis.
Results
Mtor Activity Is Necessary for Normal Development of the Kidney. To study the role of the Mtor pathway in nephron development, we deleted Mtor in NPCs using Six2 TGC+/tg (14) and the Mtor f/f alleles (23) . Reciprocally, we deleted Tsc1 using a similar strategy. Notably, the Six2 TGC+/tg allele is not benign: Fewer nephrons form in hemizygotes relative to wild type (see below). Since a large fraction of gravid dams carrying a litter with Tsc1 hemizygote kidneys delivered prematurely (before the Six2 TGC+/tg controls), we assigned age to all mice in this study as postcoitum days (PCD) based on the plug date.
One-quarter of the pups born to a Six2 TGC+/tg ; Mtor +/f male mated with an Mtor f/f female died within 2 d and displayed severe generalized edema ( Fig. 1A ) not seen in other mice lacking nephrons (e.g., Notch mutants) (24) . Genotyping confirmed complete loss of Mtor in these pups; no Mtor-null mice survived longer than 2 d. The kidneys of Mtor mutants were pale and dysplastic ( Fig. 1B) , with tubules in the parenchyma, paucity of glomeruli, and multiple cysts noted in the collecting ducts ( Fig. 1 C and D). These results demonstrate that Mtor activity is essential for proper kidney development.
Although complete loss of Mtor led to dysplastic and dysfunctional kidneys, we next explored the hypothesis that Mtor signaling might still affect nephron endowment in hemizygotes. Loss of one Mtor allele led to a 24% decrease in the kidney/body weight ratio at PCD19.5 compared with Six2 TGC+/tg mice (0.47 ± 0.03 vs. 0.624 ± 0.02, P < 0.005), and to a 42% decrease in the ratio compared with wild-type mice (0.47 ± 0.03 vs. 0.9 ± 0.03, P < 0.005) ( Fig. 2A) . Accordingly, nephron counts were significantly (P < 0.005) lower in Six2 TGC+/tg ; Mtor +/f kidneys (1,140 ± 139) compared with both controls: Six2 TGC+/tg (2,850 ± 3) and wild type (5,100 ± 377.5) ( Fig. 2B ), reflective of impaired nephrogenesis. As Six2 TGC+/tg itself affects nephrogenesis, Six2 TGC+/tg mice serve as controls in this study.
We then assessed the contribution of postnatal nephrogenesis in Mtor hemizygotes. Six2 TGC+/tg ; Mtor +/f P30 kidneys had 22.5% fewer nephrons than Six2 TGC+/tg controls (13,382 ± 389 vs. 17,250 ± 194, P < 0.0001) and 59% fewer nephrons than wildtype kidneys (13,382 ± 194 vs. 27,967 ± 298, P < 0.0001) ( Fig.  2C) . Notably, at P200 Six2 TGC+/tg animals developed albuminuria ( Fig. S1A ). Despite reduced nephron numbers, glomerular function, assessed in aggregate by serum creatinine (Fig. S1B ), blood urea nitrogen (BUN) levels (Fig. S1C ), and albuminuria, was not further compromised in Six2 TGC+/tg ; Mtor +/f ∼ P200 mice relative to Six2TGC +/tg controls.
Tsc1 Loss Is Lethal Due to Severe Renal Tubular Lesion. While Mtor loss may compromise progenitor survival due to metabolic insufficiency, it is possible that elevated Mtor activity would accelerate the cessation of nephrogenesis. To explore this, we first deleted Tsc1 in NPCs. Although Six2 TGC+/tg Tsc1 f/f pups (henceforth, "Tsc1-null kidneys") were born at the expected Mendelian frequencies and had a normal appearance at birth, they failed to survive longer than 48 h, consistent with renal failure. Tsc1-null kidneys produced urine throughout gestation, as demonstrated by amniotic fluid volumes similar to those in hemizygous littermates and the presence of urine in the bladder when pups were killed at PCD19.5 ( Fig. S2A ). Accordingly, and in contrast to Mtor-null kidneys, no glomerulopathy was identified in histological sections of Tsc1-null kidneys.
Strikingly, Tsc1-null kidneys displayed severe proximal tubular lesions: H&E staining showed that most cortical proximal tubules in Tsc1-null kidneys lacked a patent lumen compared with wild-type tubules, and tubular epithelial cells frequently exhibited a random orientation of the nuclei in contrast to the orderly basilar location in wild-type tubules ( Fig. 3 ). To quantify the degree of tubular lesion, we counted the fraction of LTL + tubules with a patent lumen in Tsc1-null and wild-type kidneys. All control LTL + tubules had a patent lumen; ∼90% of LTL + tissues in the Tsc1-null kidneys lacked a lumen ( Fig. S2 B and C) . Tubular lesions were detected as early as PCD15.5 ( Fig. 3 ). To further characterize the phenotype, we performed periodic acid Schiff (PAS) staining on Tsc1-null and control embryonic kidneys to examine the brush border in cortical proximal tubule cells (Fig.  4A ). The PAS stain generally showed no well-developed brush border along the apical surface and a lack of intracytoplasmic resorption droplets, both findings divergent from wild-type stains and indicative of loss of tubular cell polarity. Ultrastructural analysis confirmed the lack of a brush border in swollen proximal tubule cells with large eccentric nuclei. The normal number and the distribution of mitochondria implied that some forms of active transport may still exist. Glomerular morphology was unaffected by Tsc1 loss, consistent with the production of urine. The lesion was limited to the cortical proximal tubules; although it did not obstruct urine flow, it was severe enough to compromise survival (Fig. 4B ). While we cannot rule out the possibility that loss of Tsc1 in other Six2-expressing tissues (e.g., cranial nerves and dorsal root ganglia) compromised the animals, at birth they were viable, motile, and feeding normally.
We postulate that the mechanism most likely to impose rapid demise may be impaired tubular function driving the accumulation of electrolytes in the blood and leading to fatal arrhythmia.
Tsc1-Hemizygous Kidneys Have More Nephrons than Controls in Two
Independent Models. We next studied the effect of removing one Tsc1 allele on nephron numbers. We confirmed that hamartin levels were reduced by Western blot analysis of purified NPCs (Fig.  S3) . Surprisingly, the kidney/body weight ratio of the Tsc1 hemizygotes (1.5% ± 0.05) was indistinguishable from that of wild-type mice (1.5% ± 0.05, P = 0.49) and was 22% higher than that of Six2 TGC+/tg mice in adulthood (1.22% ± 0.04, P < 0.05) ( Fig. 5A ). Furthermore, deletion of one copy of Tsc1 in kidney progenitors restored nephron numbers at P30 to the wild-type levels (Fig. 5B) .
The average nephron number in Six2 TGC+/tg mice was 17,180 ± 261, significantly lower than that in wild-type mice (25,769 ± 1,756, P < 0.001); by contrast, the average nephron number in Tsc1-hemizygous kidneys (26,640 ± 514, P = 0.66) was indistinguishable from wild-type kidneys and was significantly higher than in Six2 TGC+/tg kidneys (P < 0.0001). Overall, the loss of one Tsc1 allele in NPCs increases kidney size and nephron numbers in the Six2-Cre background without any apparent impact on viability or fecundity. The loss of a Tsc1 allele may act only to correct the uncharacterized defect in Six2 +/TGC (a Bac insertion transgene). To address this possibility we used Fgf20 +/Cre mice (25), a knockin line increasing progenitor exit by a fraction due to reduced Fgf20/ Fgf9 signaling (17, 18) . Again, we observed a significant increase in nephron numbers in Fgf20 +/Cre ; Tsc1 +/f mice, which became statistically indistinguishable from wild type (Fig. 5D ). This line serves as an independent control confirming that the reduction in hamartin did not act solely by countering the defect introduced by the Six2 TGC transgene.
Increased Perdurance of Tsc1-Hemizygous Progenitors in the Niche.
Hamartin could act by increasing niche numbers, by increasing progenitor proliferation, by prolonging nephrogenesis, or by other mechanisms. Blinded observers quantified niches and progenitors by tomography-based counts on littermates with the genotypes wild type, Six2 TGC+/tg , and Six2 TGC+/tg ; Tsc1 +/f on PCD15.5 and PCD19.5. Cell number per niche was indistinguishable in the three groups at both ages. Although they trended upward at PCD19.5 in Six2 TGC+/tg ; Tsc1 +/f mice, niche numbers were statistically indistinguishable in Six2 TGC+/tg and Six2 TGC+/tg ; Tsc1 +/f mice and were higher in wild-type mice on PCD15.5 and PCD19.5 (Fig. 6 ).
To determine when NPCs were exhausted (typically by P3 in mice), we stained PCD22.5-PCD25.5 kidneys (P3-P6 in Six2 TGC+/tg mice) from the genotypes mentioned above for Six2 (MM) and cytokeratin 8 (UB). For all genotypes, Six2 + NPCs were identified on PCD22.5 but were absent on PCD24.5 (P5 in controls). At PCD23.5, controls (four wild type and two Six2 TGC+/tg ) lacked Six2 + NPCs, while many niches in all seven Tsc1 hemizygotes contained Six2 + progenitors ( Fig. 7A and Fig. S4 ). As an additional control, age-matched wild-type (Tsc1 +/f ) littermates exposed to the same uterine environment as Six2 TGC+/tg ; Tsc1 +/f pups were examined; no Six2 + niches were observed. Finally, Six2 + progenitors, and thus nephrogenesis, persisted an additional ∼24 h in the Fgf20 +/Cre ; Tsc1 +/f kidney as well (Fig. S4C ). Importantly, since none of the wild-type littermates had Six2 + progenitors at that age (Fig. 7B ), the gain in nephrons is the result of the increased lifespan of NPCs hemizygous for Tsc1.
Tsc1-Hemizygotous Renal Progenitor Cells Have Higher Engraftment
Rate. The above observation suggests a possible shift in the rate of NPC aging. To address this, we investigated how progenitor engraftment was affected by reduced hamartin activity. Deletion of Tsc1 increases the activity of Mtor, which may be driving the "aged" signature in our single-cell RNA-sequencing (RNA-seq) Fig. 3 . Severe tubular lesions in kidneys with complete loss of Tsc1. H&E staining of kidneys from different embryonic stages (PCD15.5-PCD19.5) and from wild-type (1), Tsc1-hemizygous (2), and Tsc1null (3) kidneys. Note the complete occlusion of tubular lumen by large cells that lost cellular polarity as shown by lack of brush borders and atypical nuclear location. Note also that the glomeruli appear normal in all three genotypes. Images were acquired with a 20× objective. analysis (17) . If elevated Mtor activity caused poor engraftment of older progenitors, we anticipated that Tsc1-deficient progenitors would engraft poorly relative to same-age wild-type cells. Alternatively, if Mtor activity was not impeding engraftment, but hamartin activity was, we expected to see improved engraftment.
We used an ex vivo transplantation assay to differentiate between these hypotheses. The engraftment potential of NPCs declines with time, as older NPC tend to exit the niche and differentiate in larger numbers than younger cells. To determine the performance of PCD18.5 Tsc1 +/f progenitors engrafted relative to PCD12.5 progenitors, we FACS-purified PCD18.5 Six2 TGC+/tg ; Tsc1 +/f ; Rosa +/tdTomato old progenitors (red+green, due to GFP expressed from the Six2 TGC+/tg allele) and PCD12.5 Six2 TGC+/tg ; CAG-eCFP +/tg young progenitors (blue+green). These cells were injected in a 1:1 ratio into the cap mesenchyme (CM) of a PCD12.5 recipient kidney explant. After 4 d the injected kidneys were fixed and stained for markers of MM and UB (Six2 and cytokeratin 8, respectively); we then quantified the number of red and blue Six2 + cells in z stacks acquired by confocal imaging (17) . To normalize the data across experiments, we calculated the percentage of red and blue cells out of the total injected cells remaining in the niche at day 4. IMARIS software enabled analysis of the engraftment rate; the young cells engrafted better than old cells (86 ± 3% vs. 13 ± 3%, P < 0.0001, 11 sites injected on three dates) ( Fig. 7C) . Therefore, the reduction in Tsc1 dosage did not alter the negative effect of aging.
We next tested if Tsc1 loss impacted relative engraftment by comparing same-age cells of different genotypes. We FACSpurified PCD18.5 Six2 TGC+/tg ; Tsc1 +/f ; Rosa +/tdTomato (red+green, Tsc1-hemizygote) and Six2 TGC+/tg ; CAG-eCFP +/tg (blue+green, control) progenitors and mixed them at a 1:1 ratio. When populations of PCD18.5 progenitors were injected into the CM of a PCD12.5 host kidney, Tsc1-hemizygote progenitors had a significant engraftment advantage compared with the controls (85 ± 5% vs. 15 ± 4%, P < 0.0001, 10 sites injected on five dates) ( Fig. 7D) . Therefore, although Tsc1 loss did not reverse the overall effect of aging on engraftment, decreased hamartin in NPCs does improve the cell engraftment rate.
The Effect of Tsc1 on Nephron Number and Proximal Tubules Is Agnostic to Mtor Dose but Requires both Alleles of Raptor. The increase in nephron numbers could result exclusively from elevated Mtor activity, from reduced hamartin function(s) unrelated to Mtor signaling, or both. To differentiate between these possibilities, we examined nephron numbers in compound hemizygous (Six2 TGC+/tg ; Mtor +/f ; Tsc1 +/f ) mice. Removal of one Mtor allele resulted in reduced nephron numbers (Fig. 2 ). If this reflected enhanced inhibition of Mtor complex(es) due to an increased Tsc/Mtor ratio, we would expect nephron numbers in Six2 TGC+/tg ; Mtor +/f ; Tsc1 +/f kidneys to return to the levels seen in Six2 TGC+/tg kidneys. Instead we found that Six2 TGC+/tg ; Mtor +/f ; Tsc1 +/f and Tsc1-hemizygous kidneys were indistinguishable: At P30, the average nephron number in Six2 TGC+/tg ; Tsc1 +/f mice (21, 355 ± 1,819) is similar to the average number in Six2 TGC+/tg ; Mtor +/f Tsc1 +/f mice (19,325 ± 1,822, P = 0.46). Both were significantly higher than in Six2 TGC+/tg control mice (13,838 ± 755, P = 0.01) (Fig. 5C ). We concluded that Mtor-independent hamartin activity limits nephron number and that the loss of one Tsc1 allele alleviated this restriction.
To test whether the tubular lesions of Tsc1-null kidneys can be reversed by decreasing Mtor activity in progenitors, we mated Six2 TGC+/tg ; Mtor +/f ; Tsc1 +/f males with Tsc1 f/f females; 12.5% of the pups had the relevant genotype (Six2 TGC+/tg ; Tsc1 f/f ; Mtor +/f ), all of which died within the first 2 d of life regardless of their Mtor genotype. The fraction of tubules displaying lesions under light microscopy in Six2 TGC+/tg ; Tsc1 f/f ; Mtor +/f kidneys was the same as noted in Tsc1-null kidneys (Fig. S2D) . Thus, the frequency and severity of the tubular lesions caused by complete deletion of Tsc1 are not modified by the Mtor dose.
Finally, we asked whether the scaffold protein Raptor was involved in the Tsc1 phenotypes. Whereas Six2TGC +/tg ; Mtor +/f kidneys contained significantly fewer nephrons than Six2TGC +/tg kidneys (Fig. 2) , nephron numbers in Six2TGC +/tg ; Rap +/f (n = 4) kidneys were statistically indistinguishable from Six2TGC +/tg (n = 5) kidneys (Fig. 6D) . Although Raptor and the Mtor kinase form MtorC1, Raptor may be in excess such that the loss of free Raptor had no impact whereas the loss of Mtor did. If Raptor (1), Fgf20-Cre (5), and Fgf20-Cre Tsc1 +/f (6) kidneys. Glomeruli were counted from a single kidney removed from pups aged between P7 and P11. All litters were born at the same time as controls. *P < 0.05. 5 (1a, 2a, and 3a) and PCD19.5 (1b, 2b, and 3b). (D) The Tsc1-mediated increase in nephron number requires Raptor. Shown are nephron counts in wild-type controls (1), Six2 TGC+/tg (4), Six2 TGC+/tg Rap +/f (5) , and Six2 TGC+/tg ; Rap +/f ; Tsc1 +/f (6) kidneys. Glomeruli were counted from a single kidney removed from pups aged between P7 and P11. All litters were born at the same time as controls. *P < 0.05; *** P < 0.0001. activities were mediated via MtorC1, we expected that reducing hamartin levels would elevate nephron number in Rap hemizygotes as it did in Mtor hemizygotes. Surprisingly, loss of Tsc1 in Six2TGC +/tg ; Tsc1 +/f ; Rap +/f kidneys (n = 5) had no impact on nephron numbers (Fig. 6D ). These series of genetic experiments suggest a complex mechanism by which hamartin regulates nephrogenesis duration in mice, proposed in Fig. S6 .
Discussion
Here we describe a role for hamartin in regulating NPC exhaustion during kidney development. Complete deletion of either Mtor or Tsc1 in mice NPCs led to postnatal lethality but apparently by different mechanisms. Mtor-deficient NPC failed to develop a functional kidney, reminiscent of the loss of Mtor in other stem cell compartments (26) (27) (28) (29) (30) (31) . The lethal phenotype reflects the vital role of the kidney in neonates: In utero, the filtering function of the kidney is replaced by the maternal placenta.
Complete deletion of Tsc1 spared the glomerulus but disrupted cortical proximal tubule morphology with loss of the brush border and minimal luminal space. The proximal tubules act in resorption and homeostasis of glucose, ions, and water; the loss of Tsc1 must have rendered them sufficiently impaired to cause lethality. This phenotype is reminiscent of one described previously (32) in which a later, mosaic deletion of Tsc1 in proximal tubules, glomeruli, and ducts resulted in severe, MtorC1-dependent polycystic kidney. Our results reflect an earlier, fully penetrant effect of hamartin that is Mtor independent.
Importantly, hemizygous deletion of Tsc1 increased nephron numbers in Six2 TGC+/tg Tsc1 +/f kidneys, restoring them to the level seen in the wild type. While environmental factors such as a highprotein diet (33) can increase nephron endowment in rats, few genetic manipulations can cause the same effect (34) . We found that the number of nephron progenitors and niches were the same in Tsc1 +/− and controls at PCD15.5 and PCD19.5. However, Tsc1 +/− kidneys displayed prolonged nephrogenesis, with Six2 + NPCs detected at PCD23.5 in a fraction of the niches, while there was no detectable Six2 staining past P25.5/PCD22.5 in control mice. Extended nephrogenesis by even a fraction of a day can account for the observed increase in nephron number.
Extended nephrogenesis in Tsc1 hemizygotes was consistent with the effect of losing one Tsc1 allele on the behavior of individual NPCs. Our explant system permits simultaneous interrogation of genetically defined cells engrafted in genetically defined environments. Importantly, we found that older NPCs lacking one Tsc1 allele have significantly higher engraftment rates than wild-type NPCs of the same age, as is consistent with a prolonged nephrogenic period and, presumably, a slower rate of aging. Note that not all NPCs have to display these properties for a gain of 25% in nephron numbers. Because hamartin loss impacted both Six2 TGC+/tg and Fgf20 +/Cre NPCs, its impact implies a more general mechanism that compensates indirectly for the deficiency in these models.
In humans, tuberous sclerosis disease is caused by loss of function of TSC1 or TSC2. Kidney involvement manifests with angiomyolipoma (AML) and cysts, which contribute to bleeding and CKD, respectively. It is not known whether newborns with TSC1 loss have more nephrons at birth, as any gain may be obscured by the secondary disease complications. It is possible that an increased nephron number offers a physiological advantage, as cysts promote nephron loss. In AML, in addition to germline loss of TSC1 or 2, somatic loss of heterozygosity is frequently identified (35, 36) . We found the complete deletion of Tsc1 in NPCs leads to severe and lethal tubular lesions, and others have demonstrated severe cysts in Tsc1-null kidneys (32) . Therefore, the loss of heterozygosity may lead to similar, mTOR-independent tubular lesions and eventually, in an mTORC1-dependent manner, to cystogenesis.
Inhibition of mTOR by rapamycin revolutionized tuberous sclerosis management and was particularly helpful in treating hamartomas. However, we have shown that viability was not restored and that the severity of the tubular lesions in Tsc1-null kidneys was not ameliorated by Mtor deletion. In addition, it did not modify nephron numbers in Six2 TGC+/tg Tsc +/− kidneys. It should be noted that Mtor deletion could affect MtorC1, MtorC2, and other Mtor-containing complexes (37) . Since reduced hamartin levels increase nephron number in Mtor, Fgf20, and Six2 TGC hemizygotes but not in Raptor hemizygotes, we conclude that hamartin activities are Mtor independent but Raptor dependent. This is reminiscent of recent reports that free Raptor has mTOR-independent activity (38) , which hamartin may be able to modulate (Fig. S6) .
Several questions remain to be addressed by future investigation. The molecular mechanisms behind our observed Tsc1 +/− NPC niche retention and higher engraftment rates remain unknown, as are the hamartin targets involved. Hamartin and tuberin form a complex that negatively regulates the Rheb (Ras homolog enriched in brain) GTPase, the main regulator of mTORC1. Hamartin also interacts with other pathways that affect nephrogenesis: For example, it can modulate TGF-β/Smad2/3 signaling independently from tuberin (39) . Smad signaling has an important role in kidney development via regulation of NPC exhaustion (20) . However, we could not detect changes in the level of phospho-Smad in Tsc1 hemizygotes ( Fig. S5 ). Our genetic analysis suggested that hamartin impacts nephron number independently of Mtor or the dosagesensitive Fgf20 but that its activity does require Raptor. We speculate that hamartin may participate in balancing the impact of free Raptor on nephrogenesis. When hamartin levels are reduced, a net positive effect is gained (Fig. S6 ). The pathogenesis of Tsc1 −/− -associated tubular lesions remains to be fully characterized, and, last, the implications for human health need to be explored. At present, the field is focused on modulating Mtor; our study suggests Mtor-independent targets should also be considered.
In conclusion, we find that a reduction in hamartin has a net positive effect on nephron number by enabling progenitor expansion, acting independently of the mTor complex but requiring Raptor. This suggests distinct targets and offers a therapeutic path toward increasing nephron numbers in premature newborns. Over the long run, augmenting nephron numbers could also help address the high rates of adult renal and cardiovascular disease. These findings may also provide a model that will enhance our understanding of the initial steps in the process leading to AML and cyst formation in tuberous sclerosis patients.
Materials and Methods
Animals. All mice were maintained in the Cincinnati Children's Hospital Medical Center (CCHMC) animal facility according to the animal care regulations. The Animal Studies Committee of CCHMC approved the experimental protocols (IACUC2016-0022/0032). The following lines were used: Tg(Six2-EGFP/cre)1 Amc (herein Six2Cre tg/+ ) (14) , Rosa tom/tom (40) , CAG-eCFP tg/tg (herein ECFP tg/tg ), Mtor f/f (23), Fgf20 +/Cre (25) , Tsc1 f/f (41), and Rptor tm1.1Dmsa (herein Rap f/f ) (42) . 
